%D8%A3%D8%B3%D8%A8%D8%A7%D8%B1%D8%A7%D8%AC%D9%8A%D9%86%D9%8A%D8%B2AsparaginasaAsparaginaseAsparaginaseL-Asparaginasa%D8%A2%D8%B3%D9%BE%D8%A7%D8%B1%D8%A7%DA%98%DB%8C%D9%86%D8%A7%D8%B2AsparaginaasiAsparaginase%D7%90%D7%A1%D7%A4%D7%A8%D7%92%D7%99%D7%A0%D7%90%D7%96%D4%B1%D5%BD%D5%BA%D5%A1%D6%80%D5%A1%D5%A3%D5%AB%D5%B6%D5%A1%D5%A6%D5%A1Asparaginasi%E3%82%A2%E3%82%B9%E3%83%91%E3%83%A9%E3%82%AE%E3%83%8A%E3%83%BC%E3%82%BC%E0%AC%86%E0%AC%B8%E0%AD%8D%E2%80%8C%E0%AC%AA%E0%AC%BE%E0%AC%B0%E0%AC%BE%E0%AC%9C%E0%AC%BF%E0%AC%A8%E0%AD%87%E0%AC%9CAsparaginazaAsparaginaz%C4%83%D0%90%D1%81%D0%BF%D0%B0%D1%80%D0%B0%D0%B3%D0%B8%D0%BD%D0%B0%D0%B7%D0%B0AsparaginazaAsparaginaza%D0%90%D1%81%D0%BF%D0%B0%D1%80%D0%B0%D0%B3%D1%96%D0%BD%D0%B0%D0%B7%D0%B0AsparaginaseQ421534%E9%97%A8%E5%86%AC%E9%85%B0%E8%83%BA%E9%85%B6
about
P279
P3781
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaSIMPLE Chemotherapy for NK Lymphoma/LeukaemiaAnlotinib for Advanced and Refractory Natural Killer /T-cell LymphomaCombination Chemotherapy in Patients With Newly Diagnosed BPDCNPK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic LeukaemiaPETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCombination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaCombination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesHemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/ⅣTreatment of Natural Killer/T Cell Lymphoma-I/IINHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic LymphomaGAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell LymphomaErwinase Study in Patients With Acute Lymphoblastic LeukemiaBortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaAugmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic LymphomaPegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaSWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic LeukemiaRadiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's LymphomaCombination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic LeukemiaCombination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic LeukemiaCombination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaCombination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Children With Non-Hodgkin's LymphomaCombination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell LymphomasTreatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTSAdministration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic CancerAdministration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic LeukemiaRituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic LeukemiaPhase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerCombination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's LymphomaAsparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PDACPharmacogenomics of Asparaginase Induced HepatotoxicityTreatment of Hyperbilirubinemia Due to PEG-asparaginase and Inotuzumab Ozogamicin in Acute Lymphoblastic Leukemia (ALL)Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia
P4844
Q61864749-0E1A4673-26A4-4C11-BCFC-0CA5CE769E06Q61902425-FBEB5608-FAE4-4721-BB8D-1B31112DB6E8Q61904684-B693F16B-09D8-46E5-BD44-8F1C6F40FD40Q61907739-35E82A2B-09D2-43B1-9ECC-09FF9AEB7EFBQ61909556-289633E3-8398-4537-AE03-971F725627F3Q61917621-D84E7A3E-0752-42B9-9CFB-F51F9745B886Q61932952-44A4657D-C373-4705-9D90-E0205A47767CQ61933567-2A101480-DC86-498E-BCDD-2D9375503E65Q61936780-C3D0C139-1E57-41AB-9AD8-C5869F9E8BECQ61957610-C074095C-8618-4AAD-B4BA-ED033526B6B8Q61957611-E4BDB918-1C12-43AA-AE9B-0CCA0C1F3A13Q61967240-627E49A8-2AD8-44F5-8F15-86C08008FBC9Q61970041-6120354F-6220-42B4-A645-BA4C3FB842C2Q61979883-D4349EC7-EAE5-4C37-84C3-F9B897E8006EQ61980425-99A5EC58-446E-430F-ACF7-8EF5EBD71E01Q61980960-55FA0CAE-EA3D-444E-8965-03B0BF9668D2Q61981000-8E6EDF8D-421B-4841-A53E-3CC8366DE6E2Q62026003-EA7ACA0B-5D62-4AD6-B7E2-B9A7A66EDD3DQ62105324-446C26F9-FBC2-4FB9-BBC9-7C47C4B3A16DQ62106060-9478984A-0151-4260-9A7C-709F37DE2787Q62110206-98E20D29-6738-498D-8EFD-B0AF86A04070Q62110532-71140C41-45B3-4290-B636-3EA1FF2AAF47Q62110533-4E6AE5CA-C545-460F-A1A3-A6D8C7D14069Q62110587-D35D1711-86CA-4408-80BB-F8E88282A3CEQ62110671-E20C318C-07A7-4AA0-8783-C187561C984EQ62111050-F982200C-D845-4C5A-931C-314ECBF8D202Q62111058-7403E31A-04F7-4875-A0CE-C6144C15E3F1Q62111069-5B1FFDC1-6EC7-4D82-AC46-BD0C670CF58BQ63228995-44A8B875-9FD0-4BEB-8D88-2F1CF8540669Q63319090-B722C286-1CF8-4807-A3D9-A63CC5B902FBQ63319443-1CC95D2B-FDAF-4698-9F78-09C2D3C8780EQ63319451-F10050E7-1C72-48A8-BB95-DDB37086CECFQ63335973-A9E296B8-17BF-4D27-BDAC-D50FC813ED91Q63338894-3CE32F60-85ED-41C1-9BE8-AB8E8B04FE4CQ63341119-B763CBDE-977D-4EA2-8E92-DA085A3293ACQ63393038-8C95EBDF-054F-4DD7-B5B8-4C838B6A88CCQ63393577-EB4844FD-2F4C-4952-9D8C-E877EB4327C8Q63397811-186BB023-E8FC-40B8-BF6C-791252FC833DQ63398840-CACC73A2-84CF-422F-82F0-C0D397879FE6Q63535088-79A4C700-8F46-4FAE-9602-D593E21F05F9
P4844
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
class of enzymes
@en
component quimic
@oc
name
Asparaginaasi
@fi
Asparaginase
@de
Asparaginase
@nl
Asparaginasi
@it
Asparaginaza
@pl
Asparaginaza
@sh
Asparaginază
@ro
L-Asparaginasa
@es
asparaginasa
@ca
asparaginase
@en
type
label
Asparaginaasi
@fi
Asparaginase
@de
Asparaginase
@nl
Asparaginasi
@it
Asparaginaza
@pl
Asparaginaza
@sh
Asparaginază
@ro
L-Asparaginasa
@es
asparaginasa
@ca
asparaginase
@en
altLabel
Asparaginase (E. coli)
@en
Asparaginase (Erwinia)
@en
Asparaginase Erwinia chrysanthemi
@en
Crasnitin
@en
Crisantaspase
@en
Elspar
@en
Erwinaze
@en
Erwinia chrysanthemi
@en
L Asparaginasa
@es
L-Asparaginase
@de
prefLabel
Asparaginaasi
@fi
Asparaginase
@de
Asparaginase
@nl
Asparaginasi
@it
Asparaginaza
@pl
Asparaginaza
@sh
Asparaginază
@ro
L-Asparaginasa
@es
asparaginasa
@ca
asparaginase
@en
P31
P349
P486
P592
P6366
P646
P665
P1419
P2115
N0000006477
N0000146324
P231
P232
P2566
100.029.774